The impact of depressive symptoms on healthcare costs in late life: longitudinal findings from the AgeMooDe study

Objective To examine whether depressive symptoms affect healthcare costs in old age longitudinally. Design Multicenter prospective observational cohort study (two waves with nt1 = 1,195 and nt2 = 951) in Germany. Setting Community. Participants Participants aged 75 years and older recruited via gene...

Full description

Saved in:
Bibliographic Details
Main Authors: Bock, Jens-Oliver (Author) , Weyerer, Siegfried (Author) , Werle, Jochen (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: American journal of geriatric psychiatry
Year: 2016, Volume: 25, Issue: 2, Pages: 131-141
ISSN:1545-7214
DOI:10.1016/j.jagp.2016.10.011
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.jagp.2016.10.011
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1064748116302779
Get full text
Author Notes:Jens-Oliver Bock, André Hajek, Siegfried Weyerer, Jochen Werle, Michael Wagner, Wolfgang Maier, Anne Stark, Hanna Kaduszkiewicz, Birgitt Wiese, Lilia Moor, Janine Stein, Steffi G. Riedel-Heller, Hans-Helmut König
Description
Summary:Objective To examine whether depressive symptoms affect healthcare costs in old age longitudinally. Design Multicenter prospective observational cohort study (two waves with nt1 = 1,195 and nt2 = 951) in Germany. Setting Community. Participants Participants aged 75 years and older recruited via general practitioners.Measurements Depressive symptoms were assessed by the Geriatric Depression Scale (GDS). The health-related resource use was measured retrospectively from a societal perspective based on a questionnaire, covering outpatient services, inpatient treatment, pharmaceuticals, as well as formal and informal nursing care. Hybrid regression models were used to determine the between- and within-effect of depressive symptoms on healthcare costs, adjusting for important covariates. Results Six-month total cost increased from €3,090 (t1) to €3,748 (t2). The hybrid random effects models showed that individuals with more depressive symptoms had higher healthcare costs compared with individuals with less depressive symptoms (between-effect). Moreover, an intra-individual increase in depressive symptoms increased healthcare costs by €539.60 (within-effect) per symptom on GDS. Conclusions Our findings emphasize the economic importance of depressive symptoms in old age. Appropriate interventions to treat depressive symptoms in old age might also be a promising strategy to reduce healthcare costs.
Item Description:Available online 2 November 2016
Gesehen am 21.09.2018
Physical Description:Online Resource
ISSN:1545-7214
DOI:10.1016/j.jagp.2016.10.011